Article Versions Notes

Allard Q, Djerada Z, Pouplard C, Repessé Y, Desprez D, Galinat H, Frotscher B, Berger C, Harroche A, Ryman A, et al. Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life? Pharmaceutics. 2020; 12(4):380. https://doi.org/10.3390/pharmaceutics12040380

Allard, Quentin, Zoubir Djerada, Claire Pouplard, Yohann Repessé, Dominique Desprez, Hubert Galinat, Birgit Frotscher, Claire Berger, Annie Harroche, Anne Ryman, and et al. 2020. "Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?" Pharmaceutics 12, no. 4: 380. https://doi.org/10.3390/pharmaceutics12040380

Allard, Q., Djerada, Z., Pouplard, C., Repessé, Y., Desprez, D., Galinat, H., Frotscher, B., Berger, C., Harroche, A., Ryman, A., Flaujac, C., Chamouni, P., Guillet, B., Volot, F., Szymezak, J., Nguyen, P., & Cazaubon, Y. (2020). Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life? Pharmaceutics, 12(4), 380. https://doi.org/10.3390/pharmaceutics12040380